Psoriasis in skin of color: insights into the epidemiology, clinical presentation, genetics, quality-of-life impact, and treatment of psoriasis in non-white racial/ethnic …

BP Kaufman, AF Alexis - American Journal of Clinical Dermatology, 2018 - Springer
Psoriasis is a chronic inflammatory skin condition affecting diverse racial/ethnic groups
throughout the world. Large population-based studies suggest that psoriasis occurs most …

[PDF][PDF] Psoriasis in special localizations

K Dopytalska, P Sobolewski, A Błaszczak… - Reumatologia …, 2018 - termedia.pl
Psoriasis is a chronic inflammatory dermatosis affecting 1–3% of the general population.
Patients with psoriasis represent a heterogeneous population with individual disease …

Scalp psoriasis: a literature review of effective therapies and updated recommendations for practical management

M Mosca, J Hong, E Hadeler, N Brownstone… - Dermatology and …, 2021 - Springer
The scalp is one of the most commonly affected regions in psoriasis. However, scalp
psoriasis can be difficult to treat because of challenges in the delivery of therapy. Effective …

Topical treatments for scalp psoriasis

JG Schlager, S Rosumeck, RN Werner… - Cochrane Database …, 2016 - cochranelibrary.com
Topical treatments for scalp psoriasis - Schlager, JG - 2016 | Cochrane Library Skip to Content
Cookies Our site uses cookies to improve your experience. You can find out more about our …

[HTML][HTML] Manifestations and management of difficult-to-treat psoriasis

LM Aldredge, RC Higham - Journal of the Dermatology Nurses' …, 2018 - journals.lww.com
Psoriasis is a common, immune-mediated skin disorder that can manifest as multiple clinical
phenotypes. Although psoriasis affecting the scalp, face, nails, palms, soles, and …

Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 …

K Reich, C Leonardi, M Lebwohl, F Kerdel… - Journal of …, 2017 - Taylor & Francis
Background: Scalp is a frequently affected and difficult-to-treat area in psoriasis patients.
Objective: We assessed the efficacy of ixekizumab in the treatment of patients with scalp …

Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy

S Imafuku, M Zheng, Y Tada, X Zhang… - The Journal of …, 2018 - Wiley Online Library
A working group of dermatologists in Asian countries assessed the current status of psoriatic
management in the region to prepare a consensus report on topical treatment in mild to …

Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areas

D Kivelevitch, J Frieder, I Watson, SY Paek… - Expert Opinion on …, 2018 - Taylor & Francis
Introduction: Despite great therapeutic advancements in psoriasis, four notable difficult-to-
treat areas including the scalp, nails, intertriginous (including genitals), and palmoplantar …

[HTML][HTML] Secukinumab in the treatment of palmoplantar, nail, scalp, and pustular psoriasis

AW Armstrong, R Vender, L Kircik - The Journal of Clinical and …, 2016 - ncbi.nlm.nih.gov
Interleukin (IL)-17A is a key molecule in the T helper (Th) 17 pathway, and it plays a critical
role in the pathogenesis of psoriasis as well as a number of other immune-mediated …

[HTML][HTML] Dermatology: how to manage psoriasis and recognize differences in pathophysiology and presentation in patients with skin of colour

Y Lytvyn, M Sachdeva, A Mufti, J Yeung - Drugs in context, 2022 - ncbi.nlm.nih.gov
Psoriasis is a chronic inflammatory skin condition that affects diverse ethnic groups with a
wide spectrum of skin colours. There are significant differences in how psoriasis presents …